Brevan Howard Capital Management LP Moderna, Inc. Transaction History

Brevan Howard Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $318,406 - $524,155	3,146 New	3,146 $373,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $12.2 Million - $16.5 Million	-103,000 Reduced 39.62%	157,000 $19.1 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $4.07 Million - $5.91 Million	30,000 Added 13.04%	260,000 $39.9 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $32 Million - $56.7 Million	-270,000 Reduced 54.0%	230,000 $41.3 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $26 Million - $42.7 Million	220,000 Added 78.57%	500,000 $59.1 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $26.4 Million - $39.7 Million	225,000 Added 409.09%	280,000 $40 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $6.96 Million - $12.9 Million	55,000 New	55,000 $9.47 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Brevan Howard Capital Management LP with notifications on news.